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Bloom syndrome (BS) is a rare autosomal recessive disorder characterized by growth
deficiency, immunodeficiency, genomic instability, and the early development of cancers
of many types. BLM, the protein encoded by BLM, the gene mutated in BS, is localized
in nuclear foci and absent from BS cells. BLM encodes a DNA helicase, and proteins from
three missense alleles lack displacement activity. BLM transfected into BS cells reduces
the frequency of sister chromatid exchanges and restores BLM in the nucleus. Missense
alleles fail to reduce the sister chromatid exchanges in transfected BS cells or restore the
normal nuclear pattern. BLM complements a phenotype of a Saccharomyces cerevisiae sgs1
top3 strain, and the missense alleles do not. This work demonstrates the importance of the
enzymatic activity of BLM for its function and nuclear localization pattern.
INTRODUCTION
Bloom syndrome (BS) is a rare autosomal recessive
trait (German, 1993; German and Ellis, 1997). The ma-
jor clinical manifestations are small stature, sun-sensi-
tive redness of the face, immunodeficiency, male in-
fertility, a predisposition to diabetes, and the
development of early cancers of many types. Cells
derived from persons with BS exhibit increased num-
bers of chromatid gaps, breaks, and sister chromatid
exchanges (SCEs). Somatic mutations of many types
have been documented at multiple loci (reviewed in
German, 1993). Biochemical studies have demon-
strated a slow replication-fork progression and an ab-
normal distribution of DNA replication intermediates.
Some BS cell lines exhibit increased sensitivity to
DNA-damaging agents such as mitomycin C, N-ni-
troso-N-ethylurea, and ethyl methanesulfonate. Alter-
ations in several enzymes involved in DNA replica-
tion and repair have been identified in some but not
all BS cell lines (see references in Ellis et al., 1995a).
Despite this accumulation of biochemical evidence of
disturbances in DNA metabolism, no consistent defect
or candidate gene product could be identified by these
approaches.
The Bloom syndrome gene was cloned using molec-
ular haplotype analysis of affected families and posi-
tional cloning methodologies (Ellis et al., 1995a). The
mapping of the gene was facilitated by the observation
that lymphocytes from affected compound heterozy-
gotes can revert to a normal low SCE frequency phe-
notype by virtue of recombination within the two
copies of the BLM gene itself (Ellis et al., 1995b). These
normal circulating cells arise because of a rare somatic
recombination event between the maternal and pater-
nal chromosome 15s and generate cells containing a
wild-type gene. Molecular haplotype analysis of low-
SCE cells and high-SCE cells from several affected
individuals narrowed the BLM locus to a 250-kilobase
region at 1 5q 26.1. Expressed DNA sequences from
this region were selected, and a cDNA clone was
found encoding a 1417 amino acid protein with strong
amino acid sequence homology with the RecQ family
of DNA helicases. DNA sequence analysis of BLM† Corresponding author. E-mail address: nneff@nybc.org.
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cDNAs from persons with BS is consistent with reces-
sive, loss of function mutations (Ellis et al., 1995a).
The RecQ family members (Umezu et al., 1984; Gan-
gloff et al., 1994; Puranam and Blackshear, 1994; Ellis et
al., 1995a; Watt et al., 1995; Lu et al., 1996; Yu et al.,
1996; Stewart et al., 1997; Davey et al., 1998) have seven
conserved helicase motifs, inserted between unique
N-terminal and C-terminal domains of variable size.
The highest percentage of amino acid identities
(;40%) among these gene products is in the 350 amino
acid helicase region. Recent database searches predict
a small nucleic acid binding domain in the C-terminal
regions of all of the members of the RecQ family
(Morozov et al., 1997), suggesting common DNA bind-
ing/recognition features in the two helicases as well as
a region of limited identity (25%) C-terminal to the
helicase domain in all the family members. A pre-
dicted 39 to 59 exonuclease domain has been identified
in the N-terminal region of WRN (Mushegian, et al.,
1997) that is not present in the other large members of
the family.
The BLM structure is similar overall in amino acid
charge distribution and in size to Sgs1p from Saccha-
romyces cerevisiae (Gangloff et al., 1994; Watt et al., 1995;
Lu et al., 1996), the Schizosaccharomyces pombe Rqh1
gene product (Stewart et al., 1997; Davey et al., 1998),
and the human WRN gene product (Yu et al., 1996).
The S. cerevisiae SGS1 gene was identified by its phys-
ical and genetic interaction with three different topo-
isomerase genes (Gangloff et al., 1994; Watt et al., 1995;
Lu et al., 1996). Yeast cells containing sgs1 mutations
are viable but somewhat slow growing and hyper-
recombinagenic (Gangloff et al., 1994; Watt et al., 1996).
Significant numbers of spores are inviable, and an
increase in mitotic nondisjunction is found (Watt et al.,
1996), suggesting a defect in the maintenance of
genomic integrity. New data suggest a role for Sgs1p
in maintaining the stability of rDNA repeats because
the nucleolar structure appears to fragment prema-
turely in aging yeast cells containing sgs1 mutations
(Sinclair and Guarente, 1997; Sinclair, et al., 1997). The
S. pombe gene rqh11 was identified independently by
two different genetic approaches. Cells containing rqh1
mutations show a hyper-recombination phenotype
and hydroxyurea (HU)-dependent cell cycle check-
point defects or are UV-sensitive (Stewart et al., 1997;
Davey et al., 1998). Persons with Werner syndrome are
generally normal until the second decade of life, when
they begin to show symptoms of a premature aging-
like disorder (Epstein et al., 1966). Cells from persons
with Werner syndrome contain loss of function alleles
of the WRN gene and show chromosome instability
and an elevated frequency of somatic mutation
(Hoehn et al., 1975; Fukuchi et al., 1989).
Research into the pathways of DNA repair and re-
combination in bacteria has led to the proposal by
Galitski and Roth (1997) that the RecF pathway of
which RecQ is a member is responsible for the recog-
nition and repair of single-stranded gaps in the chro-
mosome. A study of recombination events in bacterio-
phage lambda demonstrates a role for RecQ in
reducing illegitimate recombinational events (Hanada
et al., 1997). The RecQ protein and most of the other
members of the RecQ family of DNA helicases have
the demonstrated ability to recognize and bind to
single-stranded gaps in vitro and displace an oligonu-
cleotide in the 39 to 59 manner (Umezu et al., 1984;
Puranam and Blackshear, 1994; Lu et al., 1996; Gray et
al., 1997; Karow et al., 1997; Bennett et al., 1998). Stud-
ies of the yeast genes suggest that the larger members
of the family may function during S phase to prevent
recombinational events between repeated sequence el-
ements in the genome that would lead to chromo-
somal entanglements. Therefore cells containing mu-
tations in the largest members of the RecQ family have
phenotypes consistent with the loss of function of an
enzyme required for genomic stability. None of these
larger gene products nor RecQ encodes an essential
gene, and most cells lacking these gene products show
alterations in recombination and genomic stability,
suggesting that the DNA helicase activity of these




Escherichia coli Expression Vectors. The BLM cDNA B3 (Ellis et al.,
1995a) was cloned into the XhoI site of the T7 RNA polymerase-
dependent expression vector pET14b (Novagen, Madison, WI) to
create plasmid A3ET. This construction contains a six-histidine
epitope tag at the amino terminus of BLM. A deletion of the C
terminus of the BLM cDNA was made from plasmid A3ET by
digesting with StuI (nucleotide 1367) and BamHI, followed by re-
closure of the plasmid. This construction (pA3NET4) was used for
antigen production (see below). Plasmid vectors were constructed
using standard DNA technology (Sambrook et al., 1989).
Mammalian Expression Vectors. The BLM cDNA R12 (Ellis et al.,
1995a) was cloned into the NotI site of mammalian expression vector
pOPRSVI-CAT (Stratagene, La Jolla, CA), replacing the CAT gene.
Three missense mutations were constructed in this normal BLM
cDNA using a site-directed mutagenesis kit (Clontech, Palo Alto,
CA). Position 672 (glutamate) was altered to arginine (A2089G)
[59-GCATAATTTTAGAACTAATCGGCTAGAGGCG-39], position
695 (lysine) was changed to threonine (AG2157CC) [59-CTGGAG-
GTGGTACCAGTTTGTGTTACC-39], and position 1055 (cysteine)
was changed to serine (G3238C) [59-CCTGATTTTTCTAAGAAA-
CACCC-39].
Yeast Expression Vectors. The normal BLM cDNA B3 was inserted
into the yeast expression vector pYES2 (Stratagene) behind the
GAL1 promoter (pB3YES3). This BLM gene was modified at the 39
end to contain a six-histidine epitope tag (pC4YES3). Plasmids were
introduced into yeast cells by LiOAc transformation (Golemis et al.,
1998). The missense mutation-containing genes, originally made in
the mammalian expression vector (above), were moved into the
yeast vector in a one-step procedure using plasmid gap-repair
(Kunes et al., 1987). Plasmid pC4YES3 DNA was digested with BglII
N.F. Neff et al.
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and SalI to create a gap of ;2 kilobases within the BLM cDNA. The
missense mutation constructions were digested with NotI to release
the BLM cDNA from the vector sequences. Approximately equal
amounts (1 mg) of digested yeast expression construction DNAs
were mixed together and transformed into AMR61 cells. Ura1 col-
onies were screened by PCR analysis and DNA sequencing to
confirm the introduction of the missense alleles. This method was
highly efficient because 20 of 20 clones analyzed by PCR and re-
striction mapping contained the new KpnI site introduced by the K
to T mutation, 2 of 2 analyzed by DNA sequencing picked up the Q
to R mutation, and 3 of 4 contained the C to S mutation. Standard
yeast media containing glucose or galactose was used (Sherman,
1991). HU was purchased from Sigma (St. Louis, MO). The S.
cerevisiae strains used in this study are W3031a 5 a ura3–1 trp1–1 can
1–100 ade2–1 leu2–3, 112 his3–11,15 (Thomas and Rothstein, 1989);
AMR59 5 a top1::LEU2 sgs1–3::TRP1 ura3–1 trp1–1 can1–100 ade2–1
leu2–3,112 his3–11,15; and AMR61 5 a top3::HIS3 sgs1–3::TRP1
ura3–1 trp1–1 can1–100 ade2–1 leu2–3,112 his3–11,15 (Lu et al., 1996).
Growth rates were measured from 36 h cultures of transformed
colonies in yeast minimal medium with 2% raffinose as the carbon
source. The cultures of cells were diluted into yeast minimal me-
dium containing 2% glucose or 2% galactose, supplemented with
needed amino acids and adenine, at an A600 nm of ;0.1 to begin the
experiment. When the optical density of the cultures began to
increase (usually 2–3 h after dilution), time points for growth rates
at 30°C were measured every 1–3 h up to 9 h.
Fibroblast Cell Transfection and SCE Analysis
Human fibroblast cell lines HG2855 (GM00637) SV40-transformed
normal and HG2522 (GM08505) SV40-transformed Bloom syn-
drome were obtained from the Coriell Institute for Medical Re-
search (Camden, NJ). HG2619 was generated in this laboratory from
a piece of skin from a normal male using standard techniques (Korf,
1997). HG2940 is a fibroblast cell line generated from a piece of skin
from a 3-y-old female with Bloom syndrome [(JePa) Bloom Syn-
drome Registry designation]. These cells were cultured in DMEM
and 4 mM l-glutamine (Life Technologies, Gaithersburg, MD) sup-
plemented with 10% fetal bovine serum (Hyclone, Logan, UT).
HG2522 cells (105) were seeded into 35-mm tissue culture wells.
After 48 h the cells were transfected with 5 mg of plasmid DNA and
7.5 mg of LipofectAMINE (Life Technologies) according to the sup-
plier’s recommendations. The cells were grown for 3 d in DMEM
containing 10% FBS and then in the same medium plus 200 mg/ml
Geneticin (Life Technologies) until clones formed. Eight clones con-
taining the normal BLM cDNA, seven clones with the control CAT-
containing plasmid, and three of each of the BLM missense muta-
tion genes were chosen for SCE analysis.
Differential staining of sister chromatids was modified from Goto
et al. (1975). Cells were cultured in the presence of 10 mM BrdU
(Sigma) in the dark at 37°C in 5% CO2 for 48 h and subsequently
were harvested by standard techniques. Slides made from the cell
suspensions fixed in methanol:acetic acid (3:1) were allowed to
air-dry overnight protected from light. Cells were stained with 50
mg/ml Hoechst 33258 (Sigma) for 10 min and rinsed in distilled
water. The preparations were mounted under a coverslip in citric
acid-phosphate buffer at pH 7.0 and were exposed to a 150-W plant
light (Durolite; Sylvania, St. Mary’s, PA) for 1–2 h at a distance of
20–25 cm. Slides were rinsed in distilled water and stained in 2%
Giemsa (Harleco, Wright Giemsa; EM Diagnostics, Gibbstown, NY)
diluted in Gurr’s buffer, pH 6.8, for 10 min. The slides were rinsed
with water and allowed to air dry. Preparations were mounted in
Permount (Fisher, Pittsburgh, PA).
Expression and Purification of BLM
Yeast cells (AMR61) transformed with plasmids containing the nor-
mal BLM cDNA and the missense alleles were grown at 30°C in
yeast minimal medium (13 Yeast Nitrogen Base, Difco, Detroit, MI)
1 2% raffinose (Sigma) 1 50 mg/ml adenine, tryptophan, histidine,
and leucine (Sherman, 1991). When the A600nm of the culture
reached 0.3–0.6, the expression of BLM was induced by adding 2%
galactose (Sigma). After 5 h, the cells were harvested by centrifu-
gation and stored frozen at 270°C.
All steps in the purification of BLM use Buffer A (50 mM HEPES,
pH 7.5, 100 mM KCl, 10% glycerol, and 0.01% NP40) and are carried
out at 4°C. Breaking buffer is Buffer A 1 5 mM b-mercaptoethanol
1 1 mM PMSF 1 13 “Complete” protease inhibitors (Boehringer
Mannheim, Indianapolis, IN) added just before use. Cells were
broken according to standard methods using acid-washed glass
beads (Golemis et al., 1998). The cleared crude lysate (10 ml of 5
mg/ml total protein) is applied to a small phosphocellulose column
(P11, Whatman) (6 3 1.5 cm diameter) equilibrated in breaking
buffer. The column is washed with breaking buffer, followed by two
washes of increasing NaCl steps (Buffer A 1 150 mM NaCl; Buffer
A 1 300 mM NaCl). After initial load and wash with breaking
buffer, 1 mg/ml each leupeptin and pepstatin, and 5 mM benzami-
dine are substituted for the protease inhibitor mixture. The BLM
elutes in Buffer A 1 700 mM NaCl. The high salt fractions contain-
ing BLM by silver staining or Western analysis (4 ml of 1–2 mg/ml
total protein) are pooled and diluted with an equal volume of Buffer
A. This fraction is bound to 0.2–0.5 ml of the Talon metal chelate
chromatography resin (Clontech) by batch incubation. The resin is
washed with wash buffer A 1 400 mM NaCl and buffer A 1 1 M
NaCl. The metal resin is then washed with wash buffer A 1 5 mM
imidazole and packed into a small column. The column is washed
with five column volumes of buffer A 1 10 mM imidazole followed
by a 20 mM imidazole wash. Elution buffer is A 1 50 mM imidazole
(yield is ;1–5 mg/l). Protease inhibitors were purchased from
Boehringer Mannheim, protein reagents and apparatus were from
Bio-Rad (Hercules, CA), and other reagents were from Sigma. Pro-
tein concentrations of final fractions are determined by comparison
to a bovine serum albumin standard (1–100 ng/lane) on an 8% SDS
polyacrylamide gel stained with silver (Bio-Rad).
Helicase Assays
Oligonucleotide Displacement Assay. The substrate for the reac-
tions consists of a [32P]-labeled oligonucleotide of 17–54 bases in
length annealed to Mp18 ssDNA. The substrate was separated from
unincorporated nucleotides and unannealed oligonucleotides by
use of a spin column (Bio-Rad 30 or Clontech 1000). Assays were
performed at 37°C using published conditions (Seo and Hurwitz,
1993). The activity of the helicase was calculated as percentage
displacement relative to 100% displacement, determined by heating
one reaction tube to 95°C before running the 12% polyacrylamide
gel (19:1) in 13 Tris borate–EDTA. The helicase displacement activ-
ity was quantitated using a Molecular Dynamics (Sunnyvale, CA)
Storm PhosphorImager and Imagequant software. One unit of ac-
tivity is that amount of enzyme that will displace 10% of the labeled
oligonucleotide in 30 min at 37°C. Single-stranded Mp18 DNA was
purchased from US Biologicals (Cleveland, OH) or New England
Biolabs (Beverly, MA). Oligonucleotides were made by Life Tech-
nologies. The oligonucleotides used for the helicase substrates were
HS1 (59-GTAAAACGACGGCCAGT-39); HS2 (59-CGACG-
GCCAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAGGAT-39);
HS3 [(dT)15HS1]; HS4[(dT)15HS2]; HS5[HS1(dT)15]; and HS6[(dT)15
HS1(dT)15]. The polarity of the BLM helicase activity was determined
using oligonucleotide HS2 labeled at the 59 end with T4 polynucleotide
kinase (Boehringer Mannheim) and [g-32P]ATP, and/or at the 39 end
using Klenow polymerase (New England Biolabs) and [a-32P]dCTP and
dGTP to extend the length to 54 bases. This oligonucleotide spans the
multicloning site of Mp18 DNA. Digestion with PstI yields two end-
labeled oligonucleotides of 26 and 28 bases situated at opposite ends.
Reactions are quantitated as described above.
DNA-dependent ATPase Activity. This assay measures the DNA-
dependent hydrolysis of [32P] Pi from [g-32P] ATP. One enzyme unit
BLM DNA Helicase and Genomic Instability
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is that amount of BLM that hydrolyzes 1 pmol of ATP per minute at
37°C with 1 mM ATP and 25 ng/ml poly dA:poly dT12. Reactions
(25–100 ml) were stopped by the addition of 5–20 ml of 0.1 M EDTA,
pH 8, 1 1% SDS. Aliquots (1 ml) of the reaction were spotted on
polyethyleneimine (Fisher) cellulose thin layer plates and devel-
oped in LiCl and formic acid as described (Seo and Hurwitz, 1993).
Substrates were purchased from Sigma (herring sperm DNA) or
Pharmacia (Piscataway, NJ) (poly dA:poly dT12). ATPase activity
was quantitated using a Molecular Dynamics PhosphorImager. Calf
intestinal phosphatase (Boehringer Mannheim) was used as a pos-
itive control for ATP hydrolysis.
Antibody Production and Purification
Plasmid A3NET3 contains the 59 end of the BLM cDNA from
translation start to the StuI site at nucleotide 1367. This T7 RNA
polymerase-dependent construction (pET14b, Novagen) was ex-
pressed in E. coli BL21 (DE3) cells by induction with isopropyl-b-
d-thiogalactoside (Studier et al., 1990). The six histidine-tagged N-
terminal region of BLM (;45 kDa) was extracted under denaturing
conditions and bound to Ni-NTA resin (Qiagen, Hilden, Germany)
according to the supplier’s recommendations. The antigen prepara-
tion was eluted in pH 4.5 buffer containing 8 M urea, neutralized
with 1 M Tris-base, and stored frozen at 270°C. Each rabbit received
50–100 mg of the antigen preparation once every 4–6 wk, and after
3 mo they began to produce detectable antibodies against BLM. The
immune sera was pooled at 4°C and mixed with an equal volume of
saturated ammonium sulfate, pH 7.0. The 50% ammonium sulfate
precipitate was collected by centrifugation, dissolved in a minimal
volume of cold 13 PBS, and dialyzed overnight at 4°C against 13
PBS. The dialysate was collected and passed at 4°C over a Sepharose
4B column (;1 ml) that contained 500 mg/ml of bound antigen. The
column was prepared from CNBr-activated Sepharose 4B (Pharma-
cia) activated and washed according to the manufacturer’s recom-
mendations. The column was washed with 10 column volumes of
13 PBS and eluted with 0.2 M glycine pH 3.5 buffer. The protein
containing fractions were neutralized with 1 M Tris-base and stored
at 4°C for daily use and at 220°C for long-term storage (Harlow and
Lane, 1988).
Western Analysis and Immunofluorescence
Cultured cells (106–107) were harvested and stored as frozen pellets
at 270°C. Whole-cell protein extracts were prepared by lysing the
cells in 5 vol of RIPA buffer (Harlow and Lane, 1987) and 13
Complete protease inhibitors (Boehringer Mannheim) and 1 mM
PMSF on ice. Protein concentrations of the cleared lysates were
determined by the method of Bradford (1976) (Bio-Rad). Equal
amounts of protein (20 mg) were loaded onto each lane of a 5% SDS
polyacrylamide mini-gel (Bio-Rad). After electrophoresis the pro-
teins were transferred electrophoretically to Imobilon PVDF mem-
branes (Millipore, Bedford, MA) overnight at 15 V in a Tris–glycine
buffer (Harlow and Lane, 1987). The dried membranes were blocked
in 13 PBS plus 5% nonfat dried milk and incubated with affinity-
purified BLM antisera diluted in the same solution plus 0.1% Tween
20 (Sigma). The membrane was developed with the ECL detection
system (Amersham) according to the manufacturer’s instructions
and exposed to BioMax x-ray film (Kodak, Rochester, NY).
Indirect immunofluorescence detection of BLM was performed
on fibroblast cells grown on Fisher Superfrost Plus glass microscope
slides (Fisher). The cells were fixed in methanol:acetone (1:1) at
room temperature for 2 min. Slides were blocked with cold 13 PBS
1 0.5% BSA (Sigma) 1 0.2% cold-water fish gelatin (Sigma) for 1 h
and stained with affinity-purified anti-BLM, followed by Texas Red-
conjugated donkey anti-rabbit secondary antibodies (Jackson Im-
munoResearch, West Grove, PA). The slides were washed with 13
PBS 1 0.4% Tween 20 and stained with DAPI using a published
protocol (Harlow and Lane, 1987).
RESULTS
Expression of Transfected Normal and Mutant BLM
cDNAs in Bloom Syndrome Cells
Bloom syndrome cells have a high frequency of SCEs
(German, 1993). This cytogenetic assay is diagnostic
for BS and was used to determine whether the normal
BLM cDNA was sufficient to reduce the frequency of
SCEs in BS cells. Plasmid constructions containing a
normal BLM, a control chloramphenicol acetyltrans-
ferase (CAT) gene, or missense mutant cDNAs were
transfected into Bloom syndrome cells (HG2522).
HG2522 is an SV40-transformed fibroblast cell line
and is used for the present experiments because these
cells have a high mitotic index for SCE assays and they
transfect reproducibly. Stable cell lines were cloned
from primary transfectant pools using limiting dilu-
tion and selection for resistance to G418 (Geneticin).
The cell lines were evaluated for SCE and for the
presence of BLM by immunofluorescence and West-
ern analysis.
Stable transfection of the normal BLM cDNA re-
duced the mean number and range of SCEs in HG2522
cells (Figure 1). A report of the complete cytogenetic
analysis of the transfection of the normal BLM cDNAs
into SV40-transformed BS fibroblasts and BS lympho-
blastoid cell lines will be published elsewhere (our
unpublished results). Cells transfected with the con-
trol CAT gene or any of the three missense BLM genes
failed to show reduction (Figure 1C). Two of the mis-
sense genes (Q672R and C1055S) were identified in
affected individuals (Ellis et al., 1995a), whereas the
third (K695T) is a constructed mutation in the ATP-
binding site (GKT/S) present in the first conserved
helicase motif. These data demonstrate that stable
transfection of the normal BLM cDNA lowers the high
SCE phenotype of BS cells, and the three missense
genes tested fail to alter the frequency of SCEs.
Normal human fibroblasts and BS fibroblasts were
evaluated for BLM expression by indirect immunoflu-
orescence and Western analysis (Figures 2 and 3).
Normal human fibroblasts have variable amounts of
nuclear localized BLM that is organized in both small
foci and more diffuse patches (Figure 2A). SV40-trans-
formed normal fibroblasts have more BLM than un-
transformed fibroblasts per microgram of total cell
protein (Figure 3, lanes 1 and 2), and the nuclear
staining pattern shows small foci and more of the
patches (Figure 2B). BS cells, either fibroblasts
(HG2940) or SV40-transformed fibroblasts (HG2522),
lack nuclear staining with BLM antibody (Figure 2, C
and D), and lack BLM by Western analysis (Figure 3,
lane 5). The HG2522 cell line is derived from an Ash-
kenazi Jewish individual [42(RaFr) Bloom Syndrome
Registry designation] and is homozygous for the
blmAsh frameshift mutation (our unpublished results)
(Ellis et al., 1995a).
N.F. Neff et al.
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When the normal BLM cDNA is transfected into
HG2522 cells, the nuclear staining with BLM antibody
is restored (Figure 2E; Figure 3, lanes 3 and 4). The
missense proteins are expressed in the stable cell lines
to a lesser extent than in the cells transfected with the
normal BLM cDNA (Figure 3, lanes 6–8). The cells
expressing the missense BLM proteins show a nuclear
staining pattern with little or no focal concentration of
Figure 1. SCE assay. (A) Metaphase chromosomes from SV40-
transformed BS fibroblast cell line HG2522 differentially stained
to show the high frequency of SCEs. (B) Metaphase chromosomes
from SV40-transformed BS fibroblast cell line HG2522 transfected
with the normal BLM cDNA. (C) A graphic display of the range
and distribution of SCEs in the fibroblast cell lines transfected
with cDNAs encoding normal and missense BLM proteins. The
mean number of SCEs per 46 chromosomes and range are as
follows: HG2522 (55 and 16–88); CAT (55 and 18–105); R12 [WT]
(24 and 5–74); Q672R (71 and 38–104); K695T (59 and 33–98); and
C1055S (67 and 39–100). The values reported for cell line HG2522
and for the R12-transfected line represent experimental baseline
numbers for these cell lines. At least 25 metaphases were counted
for each transfected cell line.
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the antigen (Figure 2, F and G). The only foci seen in
the nucleus of the cells transfected with the missense
cDNAs are a few small dots. The cells expressing the
C1055S allele have a diffuse nuclear distribution of this
missense BLM protein. The missense proteins fail to
reduce the SCEs and fail to localize in the normal
pattern.
Expression and Purification of Normal and Mutant
BLM Proteins
The normal BLM cDNA was cloned into the T7 RNA
polymerase-dependent E. coli expression vector
pET14b (Studier et al., 1990). No evidence of produc-
tion of BLM could be found in several E. coli strains
tested. This construction was truncated to make a
45-kDa N-terminal fragment of BLM for antigen pro-
duction.
The normal BLM cDNA was cloned into the yeast
expression vector pYES2 (Stratagene) under control of
the GAL1 promoter. This high copy-number plasmid
construction was transformed into S. cerevisiae AMR61
cells by complementation of the ura3–1 mutation in
the cells by the URA3 gene on the plasmid. These cells
contain sgs1 and top3 mutations as well (Lu et al.,
1996). The polyclonal rabbit BLM antibody was used
to monitor the purification (Figure 4A). Small amounts
of highly purified BLM could be recovered for assays
(Figure 4, A and B).
The normal BLM purified from yeast had DNA
helicase displacement activity (Matson and Kaiser-
Rogers, 1990; Lohman and Bjornson, 1996) (Figure 4B).
The size of the oligonucleotide (17–54 bases) or the
presence of a 59 or 39 poly(dT)15 nonhomologous tail
had no affect on the activity. All substrates tested are
used equally well by the enzyme (6 U/ng). The activ-
ity is dependent on time of incubation and amount of
enzyme and ATP (or dATP) and is inhibited .95% by
Figure 2. Indirect immunofluorescence study of BLM in the nucleus of normal, Bloom syndrome, and SV40-transformed human fibroblast
cell lines. All cells are fixed and stained with BLM antibodies, followed by donkey anti-rabbit secondary antibodies conjugated to Texas Red.
Cells in A–E are stained with DAPI. Cells in F–H are not stained with DAPI to show diffuse BLM staining. (A) Normal human fibroblasts
(HG2619). (B) SV40-transformed normal human fibroblasts (HG2855). (C) BS fibroblasts (HG2940). (D) SV40-transformed BS fibroblasts
(HG2522). (E) HG2522 transfected with the normal BLM cDNA. (F) HG2522 transfected with the Q672R cDNA. (G) HG2522 transfected with
the C1055S cDNA. (H) HG2522 transfected with the K695T cDNA.
Figure 3. Western transfer analysis of BLM proteins in cell lines
and transfected clones. Twenty micrograms of total cell protein
were loaded on each lane, and proteins were displayed on a 5% SDS
polyacrylamide gel and transferred to a PVDF membrane. Positions
of molecular weight markers and BLM are indicated by arrows.
Lane 1: SV40-transformed normal fibroblast cell line (HG2855); lane
2: normal fibroblast cell line (HG2619); lane 3: SV40-transformed BS
fibroblast cell line (HG2522) transfected with the normal BLM
cDNA (R12c41); lane 4: HG2522 transfected with the normal BLM
cDNA (R12c45); lane 5: HG2522; lane 6: HG2522 transfected with
the Q672R allele; lane 7: HG2522 transfected with the C1055S allele;
lane 8: HG2522 transfected with the K695T allele.
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substitution of a nonhydrolyzable analogue of ATP
[adenosine-59-O-(3-thio)triphosphate]. The BLM prep-
arations have DNA-dependent ATPase activity (7
U/ng). The activity is stimulated equally well by 1 mg
of single-stranded Mp18 DNA and poly(dA):p(dT)12.
The polarity of the DNA helicase activity of BLM
was evaluated using two short-labeled oligonucleo-
tides annealed to a long linear single strand. The RecQ
DNA helicases are thought to recognize and bind to
the long single-stranded gap between the two oligo-
nucleotides and displace preferentially one of the two
test oligonucleotides (Matson and Kaiser-Rogers,
1990; Lohman and Bjornson, 1996). The helicase sub-
strate HS2 anneals to the polylinker region of Mp18
ssDNA, creating a small duplex region. The oligonu-
cleotide is labeled on the 59 and/or 39 ends and di-
Figure 4. Purification and DNA helicase activity of BLM. (A) Isolation of normal and missense proteins of BLM. The left panel (lanes 1–4)
contains isolated BLM proteins transferred to a PVDF membrane and reacted with the BLM antisera. Equal amounts of recovered protein are
loaded in each lane. The right panel is a silver-stained polyacrylamide gel of the isolated proteins (lanes 5–8). Equal volumes of equivalent
fractions from each preparation are loaded to show relative recoveries of the different proteins from yeast strain AMR 61. Molecular weight
markers are indicated on the left. Lanes 1 and 5 contain normal BLM; lanes 2 and 6 contain Q672R missense protein; lanes 3 and 7 contain
C1055S missense protein; lanes 4 and 8 contain K695T missense protein. (B) Helicase activity of the normal and missense BLM proteins.
Displacement activity is measured using a 39 end-labeled oligonucleotide 54 bases long annealed to ssMp18 DNA. Lanes marked 0 and D95–5
are the substrate (no enzyme) and the product (substrate heated at 95°C for 5 min). Each reaction contains 1 ng of recovered protein: lanes
2 and 3, normal BLM; lanes 4 and 5, missense Q672R BLM; lanes 6 and 7 missense C1055S BLM; lanes 8 and 9 missense K695T BLM. (C)
Polarity of the BLM helicase. The direction of movement of the BLM helicase was evaluated using a substrate digested with PstI that creates
two oligonucleotides of different sizes at opposite ends of the long ssMp18 DNA. In experiment PstA, both ends of the same substrate
molecule were labeled (59 and 39) before digestion with PstI, and in PstB two different substrate molecules were labeled either at the 59 or
the 39 end, digested with PstI and equal amounts of each mixed together in the reaction tubes. Assays were quantitated with a Molecular
Dynamics PhosphorImager. (D) Comparison of helicase activities of normal and missense BLM proteins. Displacement activity and
DNA-dependent ATPase specific activity is shown as a percentage of normal protein activity.
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gested with restriction enzymes to create two end-
labeled oligonucleotides annealed to the linearized
long single-strand DNA. The BLM helicase preferen-
tially displaces the 28 mer versus the 26 mer in the
PstI-digested substrate consistent with a 39 to 59 move-
ment relative to the long single-stranded linear mole-
cule (Figure 4D). In experiment PstA, both ends of the
same substrate molecule were labeled and then di-
gested with PstI. In experiment PstB, the two ends
were labeled independently, and the substrates were
digested with PstI and mixed together in equal
amounts. Results were similar for both substrates.
The three genes encoding the missense alleles of
BLM were expressed, and the mutant proteins were
purified (Figure 4, A and B). These genes contain
single amino acid substitutions constructed in the
mammalian expression vector pOPRSVI using oligo-
nucleotide-directed mutagenesis. These cDNAs were
cloned directly into the yeast expression vector using
yeast plasmid gap repair (Kunes et al., 1987), replacing
the normal BLM gene. Small amounts of each mis-
sense protein were purified (Figure 4, A and B), and in
two independent experiments each preparation tested
lacked helicase displacement activity (Figure 4C).
Each preparation had ;1% the specific activity of the
normal protein, indicating some potential contamina-
tion of the preparations with a yeast helicase or an-
other DNA-binding protein (Figure 4D). The Q672R
protein has DNA-dependent ATPase specific activity
(2.7 U/ng). The other two missense protein prepara-
tions have less than measurable amounts of DNA-
dependent activity (, 1 U/ng).
These data demonstrate that the amino acid substi-
tutions found in the two BLM genes from individuals
with BS are loss-of-function mutations and not amino
acid polymorphisms. Alteration of the conserved
ATP-binding motif at amino acid 695 (GKT to GTT)
abolishes the enzymatic activity of the protein. These
results demonstrate that the normal and missense pro-
teins are expressed in AMR61 cells as stable soluble
proteins, because they are recovered in approximately
equal yields (Figure 4B) with a slight bias toward
recovery of the inactive proteins (C1055S and K695T).
The BLM proteins are isolated from a yeast strain
containing sgs1 and top3 mutations because this strain
grows well, will not form potential BLM/Sgs1p het-
erodimers, and allows investigation of the phenotype
that BLM might have in yeast.
Partial Complementation of a Phenotype of an
S. cerevisiae sgs1 top3 Strain by BLM
The plasmids containing the normal BLM cDNA, the
vector pYES2, and pSGS1 were transformed into the
wild-type parental strain W3031a (Thomas and Roth-
stein, 1989), AMR61 (sgs1 top3), and AMR59 (sgs1 top1)
cells (Lu et al., 1996). AMR61 grows as well as W3031a
(Table 1), because the sgs1 mutation suppresses the
top3 slow-growth phenotype (Gangloff et al., 1994).
AMR59 grows poorly relative to W3031a (Table 1)
because the loss of Top1p combined with an sgs1
mutation may place additional demands on the essen-
tial Top2p in haploid yeast cells (Lu et al., 1996). When
yeast Sgs1p is restored in these strains the phenotypes
reverse, i.e., AMR59 grows well (doubling time of 5 h
goes to 3 h in glucose) and AMR61 grows poorly (2 h
converts to 8 h). The expression of Sgs1p (under con-
trol of its own promoter on a high copy-number plas-
mid) does slow the growth of W3031a but not greatly
(doubling time 2 vs. 3 h in glucose).
When BLM is expressed in these strains under con-
trol of a galactose-inducible promoter, the growth of
W3031a in galactose is not greatly affected (Table 1).
AMR59 grows in galactose more slowly (10 h without
BLM and 15 h with BLM), and AMR61 grows much
more slowly (5 h vs. 20 h). The expression of BLM
under these conditions mimics the effect of Sgs1p ex-
pression in AMR61 cells but not in AMR59 cells. Ex-
pression of BLM in AMR59 slows growth rather than
enhancing it, as does Sgs1p. BLM may have just
enough structural identity with Sgs1p to interfere with
yeast Top3p function and provide additional demands
on the activity of Top2p in these cells in which Top1p
is absent. These data show that BLM partially comple-
ments the phenotypes associated with sgs1 mutations
in S. cerevisiae.
The slow growth phenotype is difficult to work with
because suppressors arise frequently (Gangloff et al.,
1994; Lu et al., 1996). To find a more stringent pheno-
type for screening BLM alleles and potentially for
selecting new mutations in BLM, the AMR61 strains
were tested on medium containing HU, based on the
observation that an HU-dependent checkpoint pheno-
type is seen in strains of S. pombe that contain mutant
hus2 alleles (Stewart et al., 1997) and some rad12 alleles
(Davey et al., 1998) of the rqh11 gene.
Strain AMR61 can grow in the presence of HU un-
der the conditions used here (Figure 5, row A). Wild-
type strains such as W3031a can grow at 100 mM HU
(our unpublished results). When Sgs1p is restored, the
cells fail to grow with increasing HU (Figure 5, row B).
Table 1. Doubling times for yeast strains
Yeast strain Carbon source
Doubling time (h)
1pYES2 1pSGS1 1pBLM
W3031a (WT) Glucose 1.8 2.6 3.1
Galactose 5.3 6.2 6.4
AMR 61 (sgs1 top3) Glucose 2.4 8.2 3.3
Galactose 5.5 12.5 19.7
AMR59 (sgs1 top1) Glucose 5.1 3.3 6.2
Galactose 10.1 6.8 14.9
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Expression of the BLM cDNA has a similar effect and
affects the cell growth at a lower concentration of HU
(Figure 5, row C). AMR61 cells expressing the mis-
sense alleles grow on HU plates as well as with the
vector alone (Figure 5, rows E–G). Because the strains
expressing the missense alleles of BLM grow on HU
plates and the normal gene does not, the helicase
activity of BLM is necessary for this phenotype in sgs1
top3 yeast cells.
DISCUSSION
This work documents assays for the function of the
normal BLM cDNA in human cells, in yeast cells, and
in enzymatic assays. Transfection of the normal BLM
cDNA reduces the high SCE phenotype of BS cells.
Similar results have been observed previously (Giesler
et al., 1997). Transfection of the normal cDNA restores
BLM to the nucleus of BS cells. BLM has enzymatic
properties in vitro consistent with its predicted mem-
bership in the RecQ family of DNA helicases. Similar
results have been reported previously (Karow et al.,
1997). Two missense alleles of BLM found in individ-
uals with clinical BS (Ellis et al., 1995a) encode full-
length BLM protein that lacks helicase displacement
activity in vitro and fails to reduce the high-SCE phe-
notype of BS cells, as does a constructed missense
mutation disrupting the helicase ATP-binding site. In
S. cerevisiae the expression of the normal BLM cDNA
from a strong inducible promoter can complement the
growth phenotype of an sgs1 top3 strain but not that of
an sgs1 top1 strain. In sgs1 top3 cells, expression of
Sgs1p or BLM creates an HU-sensitive growth pheno-
type. This phenotype is dependent on expression of a
helicase-competent BLM gene.
Normal and missense proteins are recovered from
AMR61 cells as stable, soluble proteins in approxi-
mately the same yield. This suggests that the missense
proteins fold close to the normal conformation be-
cause yeast cells do not degrade them differentially
relative to normal or package them into an insoluble
form. The Q673R missense protein has 37% of the
DNA-dependent ATPase specific activity of the nor-
mal protein, demonstrating that it retains some nor-
mal function and therefore must be close to normal
conformation.
Antibodies raised against the N-terminal region of
the BLM cDNA sequence are used here to demon-
strate the nuclear localization of BLM, its focal ar-
rangement in the nucleus, and its absence from cells
derived from persons with BS. This reagent allows the
evaluation of BS cells transfected with different BLM
alleles. The focal organization of BLM is restored to BS
cells by transfection of the normal BLM cDNA. Mis-
sense alleles in BLM are expressed in variable
amounts in the different stable transfected cell lines
and fail to localize in the numerous bright, discrete
nuclear foci that are seen by immunofluorescence
analysis of normal human cells. The significance of
this focal pattern of localization of BLM in the nucleus
of human cells remains to be determined. The lack of
extensive amino acid identities between the N- and
C-terminal domains of BLM and WRN, and the pro-
found differences between the clinical phenotypes of
the affected individuals (German, 1993; Epstein et al.,
1996), suggest specialized roles or different cellular
locations for these two helicases. Recently WRN has
been shown to be present in the nucleolus of human
cells, a location distinct from the major sites of BLM
localization (Marciniak et al., 1998), a finding consis-
tent with this hypothesis.
Differences were seen among cloned cell lines de-
rived from HG2522 cells transfected with the three
different missense alleles. These cell lines express BLM
genes from a strong constitutive promoter (RSV) and
were selected for good growth in culture. The plas-
mids encoding the two missense alleles found in
BS individuals, Q672R [139(ViKr)] and C1055S
[113(DaDe)], transfected nearly as well as the normal
BLM cDNA. The three missense alleles of BLM stud-
ied here alter amino acids that are either conserved in
all family members (Q672R and K695T) or in the ex-
Figure 5. BLM complements a phenotype of a sgs1 top3 S. cerevisiae
strain. Yeast strain AMR61 (sgs1 top3) was transformed with plas-
mids pYES2, pSGS1, and pC4YES3 (normal BLM cDNA under GAL1
control), as well as with missense alleles of BLM under galactose
control. Colonies were picked into microtiter wells, replica-plated
onto minimal plates with galactose as the carbon source, and incu-
bated at 30°C for 5 d. A comparison of the growth efficiency of these
strains on increasing concentrations of hydroxyurea (HU) is shown.
Each row displays six colonies from the transformation plates. Row
A 5 1pYES2; row B 5 1pSGS1; row C 5 1pC4YES; row E 5
1pQ672R/BLM; row F 5 1pC1055S/BLM; row G 5 1pK695T/
BLM.
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tended C-terminal homology domain (C1055S). The
C1055S missense allele showed stable accumulation of
full-length BLM, but the protein was present in a
diffuse overall nuclear staining pattern. The cells
transfected with the Q672R missense allele showed a
diffuse pattern and few small dots. These cloned cell
lines expressing the Q672R and C1055S missense pro-
teins grew fairly well and generated multiple stable
cell lines (six of six). In contrast, most of the cell lines
transfected with the helicase domain knockout allele
(K695T) died in culture (five of six and three of six in
two independent transfection experiments) and ex-
press very little stable protein. The K695T mutation
may potentially function as a dominant negative mu-
tation. What BLM is present in these surviving cells
appears to be in a few small dots per nucleus or
diffusely localized. These observations suggest that
the Q672R and K695T missense proteins can assemble
into a small number of focal nuclear structures but fail
to form as many nuclear foci as the normal BLM gene
product does.
Because the missense proteins are found in lower
amounts in these stable transfected cell lines relative
to normal BLM, the failure to reduce the high SCE
phenotype may be due simply to the lower concentra-
tion of these proteins in the selected cell lines rather
than the loss of BLM function. Another factor in this
analysis is the stable focal localization of the normal
protein and the generally diffuse pattern seen with the
missense proteins. BLM may function in these nuclear
foci, and the failure of the missense proteins to localize
into or form these numerous structures may be the
reason for their failure to reduce the SCEs. The mis-
sense alleles may accumulate in HG2522 cells to a
lesser extent than normal BLM and fail to be incorpo-
rated into nuclear foci because they are not recognized
by a protein partner because they are not folded prop-
erly. Misfolding of the missense proteins would create
an unstable molecule that would likely be targeted for
proteolysis; however, the proteins are expressed in
yeast cells as soluble proteins to approximately the
same yield, and the Q672R missense protein retains
some enzymatic activity in vitro. This indicates that
the overall structure of these proteins is likely to be
close to normal. They may fail to be localized focally
and accumulate to the same stable concentration as
normal BLM if the incorporation of BLM molecules
that are inactive but of normal conformation may form
poisonous complexes that are dispersed or unstable in
the nucleus. The K695T missense protein is especially
deleterious to the cells used in this study. This mis-
sense gene was constructed in vitro, whereas the other
two missense alleles are found in affected individuals,
consistent with the transfection efficiency in vitro. The
stability of the mutant proteins in yeast cells, the im-
munofluorescent results, and the transfection data
support the idea that the activity and location of the
missense BLM proteins and not simply the lower con-
centrations of these proteins are the essential features
of the failure to reduce the SCEs in BS cells.
DNA helicases, like topoisomerases and other en-
zymes that manipulate DNA strands, can be disrup-
tive if unregulated. The activity and localization of
these enzymes must be controlled to prevent collisions
with polymerases and alterations of DNA topology
that might disrupt gene expression. Other circumstan-
tial evidence that supports the idea that defective
RecQ helicase proteins are deleterious to the cell is the
fact that the nuclear localization signal of both WRN
and BLM is found in the last 100 amino acids of these
large proteins, suggesting a cellular safety mechanism
such that mutant helicases arising from translational
stop signals can never be nuclear-localized (Kaneko et
al., 1997; Matsumoto et al., 1997).
In sgs1 top3 S. cerevisiae cells the HU-sensitive phe-
notype seen when Sgs1p or BLM is expressed may
reflect an enhanced rate of ectopic recombination oc-
curring in these cells because HU depletion of de-
oxynucleotide triphosphate pools causes stalled and
broken replication forks (Vassilev and Russev, 1984;
Kuzminov, 1995). The stalling of the replication forks
can create additional single-stranded regions in cells
allowing the entry of these helicases into the DNA
duplex, creating additional single-stranded DNA that
can invade a neighboring DNA duplex, especially a
sister chromatid. The three missense alleles of BLM
that lack in vitro helicase activity do not confer this
HU-sensitive phenotype, demonstrating that the heli-
case activity of BLM is required. These additional
recombination events may not be resolved in a timely
manner such that cells enter mitosis with entangle-
ments, as is thought to occur in the rqh1-h2 (hus2)
mutants of S. pombe (Stewart et al., 1997). It is possible
that S and G2 cell cycle checkpoints that monitor the
completion of DNA replication and block mitosis in
the presence of DNA damage fail to recognize unre-
solved recombination junctions between sister chro-
matids as damage or as potentially deleterious. Failure
to resolve these events in BS cells in a timely and
efficient manner could lead to an elevated frequency of
nondisjunction and somatic mutation by an error-
prone repair mechanism.
Other models for the function of this helicase in-
clude a role during S/G2 phase to help remove single-
stranded DNA created by replication slippage
(Schachman et al., 1960) in AT-rich repeated-sequence
elements that may anneal ectopically or a role in un-
winding sequence-specific DNA conformations that
repeated-sequence elements may assume potentially.
An interesting relationship between Sgs1p, WRN, and
the nucleolus has been found recently by the Guarente
laboratory (Sinclair and Guarente, 1997; Sinclair, et al.,
1997; Marciniak et al., 1998), suggesting a role for RecQ
DNA helicases in the stability of rDNA repeats. Re-
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cently the telomeric regions of the chromosomes of
Ustilago maydis were isolated and found to contain
RecQ DNA helicase genes as one of the two major
middle repeated subtelomeric sequences (Sanchez-
Alonso and Guzman, 1998), suggesting a need for
multiple RecQ helicase genes in this highly recombi-
nogenic fungi.
One of the major characteristics of the few known
disorders that feature genomic instability is the poten-
tial for somatic mutation and disintegration of the
genomic complement at each cell division. Bloom syn-
drome is one of the most cancer-prone disorders
known (German, 1993). The work reported here dem-
onstrates that the DNA helicase activity of the BLM
gene product is important for the maintenance of
genomic stability and for the stable localization and
function of BLM in complexes in the nucleus of human
cells. Therefore the loss of this DNA helicase leads
ultimately to the development of cancer in persons
with BS, and the elucidation of its structure and func-
tion will lead to a new understanding of one mecha-
nism by which neoplastic cells can arise and progress
into clinical cancer in normal individuals.
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